Dr. Michael Callahan, MD
Claim this profileSaint Vincent Hospital and Health Care Center
Studies Cancer
Studies Ovarian Cancer
12 reported clinical trials
34 drugs studied
Area of expertise
1Cancer
Stage II
Stage III
Stage IV
2Ovarian Cancer
Stage III
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Michael Callahan, MD is currently running
Alpelisib + Fulvestrant
for Endometrial Cancer
This trial tests a combination of two drugs, alpelisib and fulvestrant, in patients with a specific type of endometrial cancer. These patients have a genetic mutation (PIK3CA) and their cancer grows in response to estrogen. Alpelisib targets the mutation, while fulvestrant blocks estrogen, aiming to stop cancer growth. Alpelisib is the first drug of its kind approved for use with fulvestrant based on its effectiveness in treating similar types of cancer.
Recruiting1 award Phase 210 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
More about Michael Callahan, MD
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Michael Callahan, MD has experience with
- Paclitaxel
- Letrozole
- Bevacizumab
- Cisplatin
- Dostarlimab
- Carboplatin
Breakdown of trials Michael Callahan, MD has run
Cancer
Ovarian Cancer
Serous Cystadenocarcinoma
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Callahan, MD specialize in?
Michael Callahan, MD focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage II patients, or patients who are Stage III.
Is Michael Callahan, MD currently recruiting for clinical trials?
Yes, Michael Callahan, MD is currently recruiting for 4 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Michael Callahan, MD has studied deeply?
Yes, Michael Callahan, MD has studied treatments such as Paclitaxel, Letrozole, Bevacizumab.
What is the best way to schedule an appointment with Michael Callahan, MD?
Apply for one of the trials that Michael Callahan, MD is conducting.
What is the office address of Michael Callahan, MD?
The office of Michael Callahan, MD is located at: Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana 46260 United States. This is the address for their practice at the Saint Vincent Hospital and Health Care Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.